Drug Discovery and Molecular Pharmacology Study Section [DMP]

[DMP Membership Roster] [DMP Meeting Rosters]


The Drug Discovery and Molecular Pharmacology [DMP] Study Section reviews applications concerned with discovery, design, identification, isolation, development and synthesis of novel agents that are potentially useful in cancer therapy. Emphasis is on identification of antineoplastic agents and validation with novel preclinical models for anticancer drug evaluation. Specific areas covered by DMP:

  • Novel drug discovery: identification of molecular targets of antineoplastic agents that modulate signal translation, cell cycle, differentiation, apoptosis, and hormone signaling; mechanism of action of novel agents that lead to translation of these agents in the clinic and validation of target
  • New drug development and production: identification, synthesis and isolation of novel drugs and modification of existing compounds for evaluation in both in vitro and in vivo tumor model systems
  • New technology development: development and application of new technologies for the drug discovery process, including microarray analysis, proteomics, genomics, and bioinformatics
  • Assay development: development of high throughput in vitro screens and cell-based assays for cancer therapeutics
  • Model validation: development, validation, and use of novel mammalian and non-mammalian models for anticancer therapeutic experimentation


The study sections with most closely related areas of similar science listed in rank order are:

Basic Mechanisms of Cancer Therapeutics Study Section [BMCT] 
Developmental Therapeutics Study Section [DT] 
Synthetic and Biological Chemistry A Study Section [SBCA] 
Synthetic and Biological Chemistry B Study Section [SBCB] 
Macromolecular Structure and Function A Study Section [MSFA] 
Macromolecular Structure and Function B Study Section [MSFB] 
Macromolecular Structure and Function C Study Section [MSFC] 
Macromolecular Structure and Function D Study Section [MSFD] 
Macromolecular Structure and Function E Study Section [MSFE] 
Gene and Drug Delivery Systems Study Section [GDD] 

 



Home | Contact CSR | Staff Directory | Site Map | FOIA | Disclaimer & Privacy Statements | Accessibility Statement
Last updated: November 30, 2008

National Institutes of Health National Institutes of Health   Department of Health and Human Services Department of Health and Human Services USA.gov Government Made Easy